Adipose Tissue Expandability Hypothesis
The adipose tissue expandability hypothesis explains that metabolic harm comes from fat overflowing into organs once the safe storage capacity of subcutaneous fat is full.
Plain English
Patient-Friendly Explanation
The adipose tissue expandability hypothesis explains why two people with the same amount of body fat can have very different metabolic health. Fat is safest when stored in the layer under the skin, which in some people can expand almost indefinitely. Each person has an individual limit to how far that storage can stretch; once the limit is reached, surplus energy has to go somewhere else, and it is deposited in the liver, muscle, heart and pancreas, where fat is far more damaging. So it is not only how much fat you carry but where the body can put it that decides whether blood sugar, blood pressure and liver health suffer. It explains why some people develop diabetes after modest weight gain, while others with much more fat stay metabolically well.
Medical
Clinical Definition
The adipose tissue expandability hypothesis proposes that metabolic complications of obesity arise when the capacity of subcutaneous adipose tissue to store triglyceride is exceeded, rather than from total fat mass alone; the resulting overflow of lipid into non-adipose tissues such as liver, skeletal muscle, heart, pancreatic islets and vasculature causes lipotoxicity, ectopic fat deposition, impaired insulin signalling and beta cell dysfunction. The concept was articulated by Virtue and Vidal-Puig and is supported by human and animal models of lipodystrophy, in which failure to expand adipose tissue produces severe insulin resistance and fatty liver despite minimal total fat, and by studies showing that the ability to recruit and differentiate preadipocytes and to expand subcutaneous depots tracks with metabolic health better than body mass index does. Mechanistically, limited subcutaneous expandability is influenced by genetic factors, adipose progenitor cell number and function, depot-specific differences, fibrosis and inflammation within fat tissue, and the rate of energy excess; when storage fails, adipose tissue becomes dysfunctional, with macrophage infiltration, impaired adipokine secretion and increased free fatty acid release. Clinically the hypothesis explains metabolically healthy obesity, the adverse profile seen in some lean individuals, the central role of waist circumference and visceral fat in risk prediction, and why thiazolidinediones improve insulin sensitivity despite causing weight gain by promoting subcutaneous adipogenesis. It also explains why interventions that protect subcutaneous storage capacity or reduce ectopic fat, including sustained weight loss, resistance training and improved glycaemic control, improve metabolic outcomes.
Key Insight
Why It Matters
Patients often assume the only problem is how much they weigh. The more useful question is where their body can put the fat it gains, which is why we measure waist and check liver and blood sugar rather than relying on the scale alone.
Sources
Reviewed against standard medical references.
Medically reviewed by
Family Physician & Registered Acupuncturist, Accord Medical Clinic. MBBS (NUS), Graduate Diploma in Family Medicine (NUS), Graduate Diploma in Acupuncture (Singapore College of TCM).
Last reviewed: September 2026
This page is general health education, not medical advice. Whether any treatment is appropriate for you is a decision made in consultation after assessment.
